WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013125691) METHOD FOR CLASSIFYING TEST BODY FLUID SAMPLE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/125691    International Application No.:    PCT/JP2013/054571
Publication Date: 29.08.2013 International Filing Date: 22.02.2013
IPC:
C12N 15/09 (2006.01), C12M 1/00 (2006.01), C12Q 1/68 (2006.01), G01N 33/576 (2006.01), G01N 37/00 (2006.01)
Applicants: SUMITOMO BAKELITE CO., LTD. [JP/JP]; 5-8, Higashi-shinagawa 2-chome, Shinagawa-ku, Tokyo 1400002 (JP)
Inventors: MURAKAMI Yoshiki; .
OCHIYA Takahiro;
Agent: IKEUCHI SATO & PARTNER PATENT ATTORNEYS; 26th Floor, OAP TOWER, 8-30, Tenmabashi 1-chome, Kita-ku, Osaka-shi, Osaka 5306026 (JP)
Priority Data:
2012-037586 23.02.2012 JP
Title (EN) METHOD FOR CLASSIFYING TEST BODY FLUID SAMPLE
(FR) PROCÉDÉ DE CLASSIFICATION D'ÉCHANTILLON DE FLUIDE CORPOREL DE TEST
(JA) テスト体液サンプルの分類方法
Abstract: front page image
(EN)Provided is a method for classifying a test body fluid sample into one of two groups selected from among four groups consisting of chronic hepatitis C, chronic hepatitis B, non-alcoholic steatohepatitis (NASH) and normal liver. One or more embodiments of the present invention pertain to a method for classifying a test body fluid sample into one of two groups selected from among four groups consisting of chronic hepatitis C, chronic hepatitis B, non-alcoholic steatohepatitis (NASH) and normal liver. The method involves measuring the expression level of one or more non-coding RNA within the test body fluid sample.
(FR)L'invention concerne un procédé de classification d'échantillon de fluide corporel de test dans l'un des deux groupes sélectionnés parmi quatre groupes constitués par l'hépatite chronique C, l'hépatite chronique B, la stéatohépatite non alcoolique (NASH) et un foie normal. Selon un ou plusieurs mode(s) de réalisation, l'invention concerne un procédé de classification d'échantillon de fluide corporel de test dans l'un des deux groupes sélectionnés parmi quatre groupes constitués par l'hépatite chronique C, l'hépatite chronique B, la stéatohépatite non alcoolique (NASH) et un foie normal. Le procédé consiste à mesurer le niveau l'expression d'un ou de plusieurs ARN non codant(s) dans l'échantillon de fluide corporel de test.
(JA)テスト体液サンプルを、慢性C型肝炎、慢性B型肝炎、非アルコール型脂肪性肝炎(NASH)、及び正常肝臓からなる4つのグループから選択される2つのグループのどちらかに分類する方法の提供。一又は複数の実施形態において、テスト体液サンプルを、慢性C型肝炎、慢性B型肝炎、非アルコール型脂肪性肝炎(NASH)、及び正常肝臓からなる4つのグループから選択される2つのグループのどちらかに分類する方法に関する。該方法は、前記テスト体液サンプル中の1又は複数のノンコーディングRNAの発現量を測定することを含む。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)